Accueil / Tag Archives: Contract/Agreement

Tag Archives: Contract/Agreement

Novaliq GmbH Announces Licensing Agreement with AFT Pharmaceuticals for the Distribution of NovaTears®

Monday, March 20th 2017 at 7:45pm UTC NovaTears®, A Novel Treatment for Dry Eye Disease, Is Now Available in Australia and New Zealand HEIDELBERG, Germany–(BUSINESS WIRE)– Novaliq, a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology, today announced a …

Plus »

Teewinot Life Sciences and Noramco Sign Letter of Intent to Produce Cannabinoids with Cannsynthesis™ Biocatalysis Technology

Monday, March 20th 2017 at 2:05pm UTC TAMPA, Fla. & WILMINGTON, Del.–(BUSINESS WIRE)– Teewinot Life Sciences (Teewinot), the market leader in biocatalytic technologies for the production of pharmaceutical-grade cannabinoids, and Noramco, a global leading producer of controlled-substance active pharmaceutical ingredients (APIs), today signed a letter of intent to enter the …

Plus »

Aevum Life Science signs National Marketing Agreement for Protiva Pregnancy and Protiva New Mom/Recover with Proven Women’s Healthcare Company ASCEND Therapeutics U.S. LLC

Tuesday, March 21st 2017 at 3:00pm UTC SHARON HILL, Pa.–(BUSINESS WIRE)– Aevum Life Science ™ (PROTIVA®) and ASCEND Therapeutics ® U.S. LLC (ASCEND) have launched an exclusive nationwide sales and marketing partnership for the sale of all Protiva products. Protiva Pregnancy was developed and specifically formulated to take during pregnancy to …

Plus »

SCIEX and the Children’s Medical Research Institute Announce Opening of ProCan to Advance Precision Medicine

Tuesday, March 21st 2017 at 11:00am UTC SCIEX industrialized proteomics solutions, using microflow SWATH Acquisition, will accelerate cancer research FRAMINGHAM, Mass. & SYDNEY–(BUSINESS WIRE)– SCIEX, a global leader in life science analytical technologies, has announced that Children’s Medical Research Institute (CMRI) has opened ProCan™, the Australian Cancer Research Foundation International …

Plus »

Bristol-Myers Squibb and CytomX Therapeutics Extend Worldwide Collaboration to Discover Probody™ Therapeutics for the Treatment of Cancer and Other Diseases

Monday, March 20th 2017 at 10:59am UTC Builds upon initial 2014 alliance in oncology Includes up to eight additional targets in oncology and other therapeutic areas CytomX to receive $200 million upfront payment NEW YORK & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) and CytomX Therapeutics, Inc. (Nasdaq:CTMX), …

Plus »

X-Chem Announces Strategic Collaboration with Astellas Pharma Across Multiple Therapeutic Areas

Monday, March 20th 2017 at 12:15pm UTC WALTHAM, Mass.–(BUSINESS WIRE)– X-Chem, Inc. (X-Chem), a privately held biotechnology company applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics, announced the signing of a broad drug discovery collaboration with Astellas Pharma Inc. (Astellas). The collaboration will enable …

Plus »

Pierre Fabre and H-Immune Announce Strategic Research Partnership to Develop Potentially Ground-Breaking Cancer Immunotherapies

Tuesday, March 21st 2017 at 10:00am UTC Pierre Fabre Fund for Innovation will collaborate with H-Immune to utilize In Vitro Immunization (IVI) platform for the development of fully human monoclonal antibody candidates without immunogenic side effects due to humanization Focus on solid tumors provides range of possible cancer indications as …

Plus »

PIERRE FABRE ET H-IMMUNE S’ASSOCIENT DANS UN PARTENARIAT STRATÉGIQUE DE RECHERCHE POUR LE DÉVELOPPEMENT D’IMMUNOTHÉRAPIES NOVATRICES DANS LE DOMAINE DU CANCER

Tuesday, March 21st 2017 at 10:00am UTC Pierre Fabre Fund For Innovation s’engage aux côtés de H-Immune pour utiliser sa plateforme d’immunisation in vitro pour développer des anticorps therapeutiques FULLY HUMAN, dépourvus d’effets immunogènes liés aux approches classiques d’humanisation La recherche sera axée sur les tumeurs solides, pour cibler un …

Plus »

Novaliq GmbH annonce un contrat de licence avec AFT Pharmaceuticals pour la distribution de NovaTears®

Monday, March 20th 2017 at 11:54pm UTC NovaTears®, un nouveau traitement contre la sécheresse oculaire, est désormais disponible en Australie et en Nouvelle-Zélande HEIDELBERG, Allemagne–(BUSINESS WIRE)– Novaliq, une société pharmaceutique spécialisée qui possède une plateforme d’administration de médicaments d’avant-garde, transformant des médicaments peu solubles en produits ophtalmologiques efficaces, a annoncé …

Plus »

X-Chem and Ono Enter into Multi-Target Drug Discovery Collaboration

Tuesday, March 21st 2017 at 12:15pm UTC – Agreement marks X-Chem’s third drug discovery partnership with a Japanese pharmaceutical company within 3 months – WALTHAM, Mass.–(BUSINESS WIRE)– X-Chem, Inc. (X-Chem), a privately held biotechnology company applying its innovative drug discovery platform to the generation of novel small molecule therapeutics, today …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE !
Vous appréciez cet article ? Faites-nous part de vos commentaires.
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cuZWVpLWJpb3RlY2hmaW5hbmNlcy5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMTUvMDcvU2F0cmEtMi5tcDQiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...